Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 111


42,573 cases of hepatectomy in China: a multicenter retrospective investigation.

Zhang B, Zhang B, Zhang Z, Huang Z, Chen Y, Chen M, Bie P, Peng B, Wu L, Wang Z, Li B, Fan J, Qin L, Chen P, Liu J, Tang Z, Niu J, Yin X, Li D, He S, Jiang B, Mao Y, Zhou W, Chen X.

Sci China Life Sci. 2018 Feb 2. doi: 10.1007/s11427-017-9259-9. [Epub ahead of print]


Peritumoral EpCAM Is an Independent Prognostic Marker after Curative Resection of HBV-Related Hepatocellular Carcinoma.

Dai XM, Huang T, Yang SL, Zheng XM, Chen GG, Zhang T.

Dis Markers. 2017;2017:8495326. doi: 10.1155/2017/8495326. Epub 2017 May 10. Erratum in: Dis Markers. 2017;2017:3765279.


Less Fibrotic Burden Differently Affects the Long-Term Outcomes of Hepatocellular Carcinoma after Curative Resection.

Lee HW, Choi GH, Kim DY, Park YN, Kim KS, Choi JS, Ahn SH, Han KH.

Oncology. 2017;93(4):224-232. doi: 10.1159/000477173. Epub 2017 Jun 2.


Associating liver partition and portal vein ligation for bleeding hepatocellular carcinoma in HBV cirrhosis: a safety strategy.

Levi Sandri GB, Vennarecci G, Lepiane P, Ettorre GM.

Transl Gastroenterol Hepatol. 2017 Mar 23;2:20. doi: 10.21037/tgh.2017.03.08. eCollection 2017.


Impact of Viral Etiology on Postoperative De Novo Recurrence After Hepatectomy for Hepatocellular Carcinoma in Cirrhotic Patients.

Sasaki K, Shindoh J, Nishioka Y, Margonis GA, Sugawara T, Andreatos N, Hashimoto M, Pawlik TM.

J Gastrointest Surg. 2017 Mar;21(3):487-495. doi: 10.1007/s11605-016-3344-3. Epub 2017 Jan 3.


Preoperatively staging liver fibrosis using noninvasive method in hepatitis B virus-infected hepatocellular carcinoma patients.

Gao H, Zhu F, Wang M, Zhang H, Ye D, Yang J, Jiang L, Liu C, Qin R, Yan L, Xiao G.

Oncotarget. 2017 Jan 17;8(3):4289-4300. doi: 10.18632/oncotarget.14024.


DKK1 in relation to HCV induced liver cirrhosis and HCV induced HCC curative resection.

Essa ES, Montaser BA, Badawy MT, Essa AS, Mokhtar MS.

Acta Gastroenterol Belg. 2016 Jul-Sep;79(3):309-313.


Distinct Recurrence Risk Factors for Intrahepatic Metastasis and Multicenter Occurrence After Surgery in Patients with Hepatocellular Carcinoma.

Hao S, Fan P, Chen S, Tu C, Wan C.

J Gastrointest Surg. 2017 Feb;21(2):312-320. doi: 10.1007/s11605-016-3311-z. Epub 2016 Nov 4.


Prognostic value of alkaline phosphatase, gamma-glutamyl transpeptidase and lactate dehydrogenase in hepatocellular carcinoma patients treated with liver resection.

Wu SJ, Lin YX, Ye H, Xiong XZ, Li FY, Cheng NS.

Int J Surg. 2016 Dec;36(Pt A):143-151. doi: 10.1016/j.ijsu.2016.10.033. Epub 2016 Oct 25.


Metavir and FIB-4 scores are associated with patient prognosis after curative hepatectomy in hepatitis B virus-related hepatocellular carcinoma: a retrospective cohort study at two centers in China.

Liao R, Fu YP, Wang T, Deng ZG, Li DW, Fan J, Zhou J, Feng GS, Qiu SJ, Du CY.

Oncotarget. 2017 Jan 3;8(1):1774-1787. doi: 10.18632/oncotarget.12152.


Diagnostic accuracy of APRI and FIB-4 for predicting hepatitis B virus-related liver fibrosis accompanied with hepatocellular carcinoma.

Xiao G, Zhu F, Wang M, Zhang H, Ye D, Yang J, Jiang L, Liu C, Yan L, Qin R.

Dig Liver Dis. 2016 Oct;48(10):1220-6. doi: 10.1016/j.dld.2016.06.001. Epub 2016 Jun 15.


Impact of non-neoplastic vs intratumoural hepatitis B viral DNA and replication on hepatocellular carcinoma recurrence.

Wang Q, Lin L, Yoo S, Wang W, Blank S, Fiel MI, Kadri H, Luan W, Warren L, Zhu J, Hiotis SP.

Br J Cancer. 2016 Sep 27;115(7):841-7. doi: 10.1038/bjc.2016.239. Epub 2016 Aug 18.


Postoperative hepatitis B virus reactivation in hepatitis B virus-related hepatocellular carcinoma patients with hepatitis B virus DNA levels <500 copies/mL.

Xie ZB, Wang XB, Fu DL, Zhong JH, Yang XW, Li LQ.

Onco Targets Ther. 2016 Jul 25;9:4593-603. doi: 10.2147/OTT.S104300. eCollection 2016.


Surgical treatment of double primary liver cancer: An observational study for a rare type of tumor.

Li A, Ma S, Pawlik T, Wu B, Yang X, Cui L, Wu M.

Medicine (Baltimore). 2016 Aug;95(32):e4412. doi: 10.1097/MD.0000000000004412.


Preoperative γ-glutamyl transpeptidase to platelet ratio (GPR) is an independent prognostic factor for HBV-related hepatocellular carcinoma after curative hepatic resection.

Wang WL, Zheng XL, Zhang ZY, Zhou Y, Hao J, Tang G, Li O, Xiang JX, Wu Z, Wang B.

Medicine (Baltimore). 2016 Jul;95(27):e4087. doi: 10.1097/MD.0000000000004087.


Expression of DBC1 is associated with poor prognosis in hepatitis virus-related hepatocellular carcinoma.

Ha SY, Kim JH, Yang JW, Bae H, Cho HY, Park CK.

Pathol Res Pract. 2016 Jul;212(7):616-21. doi: 10.1016/j.prp.2016.04.001. Epub 2016 Apr 7.


Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.

Liu C, Sun L, Xu J, Zhao Y.

World J Surg Oncol. 2016 Apr 2;14:100. doi: 10.1186/s12957-016-0855-z.


Prognostic factors for survival after hepatic resection of early hepatocellular carcinoma in HBV-related cirrhotic patients.

Zhu Q, Yuan B, Qiao GL, Yan JJ, Li Y, Duan R, Yan YQ.

Clin Res Hepatol Gastroenterol. 2016 Sep;40(4):418-27. doi: 10.1016/j.clinre.2015.12.007. Epub 2016 Jan 25.


Distinguished prognosis after hepatectomy of HBV-related hepatocellular carcinoma with or without cirrhosis: a long-term follow-up analysis.

Yang SL, Liu LP, Sun YF, Yang XR, Fan J, Ren JW, Chen GG, Lai PB.

J Gastroenterol. 2016 Jul;51(7):722-32. doi: 10.1007/s00535-015-1146-0. Epub 2015 Nov 25.


Laparoscopic liver resection for hepatocellular carcinoma in cirrhotic patients: single center experience of 90 cases.

Ettorre GM, Levi Sandri GB, Santoro R, Vennarecci G, Lepiane P, Colasanti M, Felli E, de Werra E, Colace L, D'Offizi G, Montalbano M, Visco U, Maritti M, Antonini M, Santoro E.

Hepatobiliary Surg Nutr. 2015 Oct;4(5):320-4. doi: 10.3978/j.issn.2304-3881.2015.06.13.

Supplemental Content

Loading ...
Support Center